<?xml version="1.0" encoding="UTF-8"?>
<p>By inhibiting, 
 <italic>in vivo</italic>, TNF-
 <italic>α</italic>, lipopolysaccharide inflammatory induced cell influx, IL-6, protein concentration in bronchoalveolar lavage fluid, and NF-κB activation in the lung, thymol could be a promising therapeutical agent for acute lung injury [
 <xref rid="B112" ref-type="bibr">112</xref>].
</p>
